DJ G1 Therapeutics Is Maintained at Buy by Needham
Ratings actions from Benzinga: https://www.benzinga.com/stock/GTHX/ratings
(END) Dow Jones Newswires
February 25, 2021 06:28 ET (11:28 GMT)
DJ G1 Therapeutics Price Target Cut to $68.00/Share From $74.00 by Needham
Ratings actions from Benzinga: https://www.benzinga.com/stock/GTHX/ratings
(END) Dow Jones Newswires
February 25, 2021 06:28 ET (11:28 GMT)